7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride has been researched along with Vomiting in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SH; Kim, WB; Lee, CI; Lee, JJ; Lee, KH; Lee, MG; Lee, SD; Rha, SY; Roh, JK; Shim, HJ; Yang, J | 1 |
1 trial(s) available for 7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride and Vomiting
| Article | Year |
|---|---|
Phase I clinical trial: pharmacokinetics of a novel anthracycline, DA-125 and metabolites. Single dose study.
Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting | 1998 |